New research reveals that patients who stop using new weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise programs.
Research printed in a leading health publication shows that while overweight individuals often shed substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users buying such drugs need to be cognizant of the danger of fast weight regain when the medication ends," warns researcher Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment weight in about 18 months.
Analyzing Treatments
The research, which looked at dozens of trials involving over 9,000 of patients, compared the outcomes of these new drugs with older methods.
Researchers emphasize that individuals who shed pounds through diet and exercise usually see a less rapid creep back—around 100 grams monthly—once they finish.
Explaining the Quick Regain
Doctors suggest the mode of action of the injections is key to understanding the heightened rebound.
These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Issue?
Health authorities recommend the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Many experts contend that, considering the likelihood of weight regain, the therapy is often long-term.
This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the chronic character of excess weight," comparing it to managing conditions like high blood pressure.
User Experiences
People who have come off the jabs describe a intense resurgence of appetite.
"It felt as if a switch that goes on and I was suddenly ravenous," described one woman.
This difficulty is compounded if individuals have not established lasting lifestyle or habit modifications during treatment.
Widespread Interest
Survey data suggest that millions of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Adoption is higher among women than males.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, experts emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic fix and long-term success hinges on integrated lifestyle management.
